Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
J Endocrinol Invest
2012 Oct 01;359:835-40. doi: 10.3275/8191.
Show Gene links
Show Anatomy links
Glycated hemoglobin in diagnosis of diabetes mellitus and pre-diabetes; validation by oral glucose tolerance test. The Tromsø OGTT Study.
Hutchinson MS
,
Joakimsen RM
,
Njølstad I
,
Schirmer H
,
Figenschau Y
,
Jorde R
.
???displayArticle.abstract???
BACKGROUND: Glycated hemoglobin (HbA(1c)) 6.5% has recently been recommended by the World Health Organization (WHO) and the American Diabetes Association (ADA) as an alternative diagnostic criterion for diabetes mellitus (DM).
AIM: To evaluate HbA(1c) as an alternative to oral glucose tolerance test (OGTT) for diagnosis of DM and pre-diabetes and to find the optimal HbA(1c) cut-off points for DM and pre-diabetes in our population.
SUBJECTS AND METHODS: The subjects were recruited from the Tromsø Study, performed for the 6th time in 2007-2008 with 12,984 participants. All subjects with HbA(1c) in the range 5.8-6.9% and a random sample of subjects with levels 5.3-5.7% were invited to an OGTT.
RESULTS: Among 3476 subjects who completed the OGTT, 199 were diagnosed with DM. The best sensitivity (69.8%) and specificity (81.8%) were found at HbA(1c) 6.2%. For HbA(1c) 6.5% we found a sensitivity of 34.7% and specificity 97.1%. The best cut-off points for impaired fasting glucose (no.=314) and impaired glucose tolerance (no.=404) were found at HbA(1c) 5.9% and 6.0%, respectively. Pre-diabetes detected only by OGTT was associated with worse metabolic characteristics than pre-diabetes detected only by HbA(1c).
CONCLUSIONS: The optimum HbA(1c) cutoff point for DM in our population was lower than that proposed by WHO and ADA. To establish more precisely the HbA(1c) levels predictive of micro- and macro-vascular complications, long-term prospective studies are needed. Population- specific optimum cut-off points may be necessary.
,
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.
1997, Pubmed
,
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.
1997,
Pubmed
American Diabetes Association,
Diagnosis and classification of diabetes mellitus.
2010,
Pubmed
Bonora,
High-normal HbA1c is a strong predictor of type 2 diabetes in the general population.
2011,
Pubmed
Colagiuri,
Epidemiology of prediabetes.
2011,
Pubmed
Colagiuri,
Glycemic thresholds for diabetes-specific retinopathy: implications for diagnostic criteria for diabetes.
2011,
Pubmed
Cosson,
A large proportion of prediabetes and diabetes goes undiagnosed when only fasting plasma glucose and/or HbA1c are measured in overweight or obese patients.
2010,
Pubmed
Cosson,
What would be the outcome if the American Diabetes Association recommendations of 2010 had been followed in our practice in 1998-2006?
2011,
Pubmed
Davidson,
Effect of age and race/ethnicity on HbA1c levels in people without known diabetes mellitus: implications for the diagnosis of diabetes.
2010,
Pubmed
Engelgau,
Comparison of fasting and 2-hour glucose and HbA1c levels for diagnosing diabetes. Diagnostic criteria and performance revisited.
1997,
Pubmed
Gomyo,
Effects of sex, age and BMI on screening tests for impaired glucose tolerance.
2004,
Pubmed
Hawkins,
Differences in HbA1c between Caucasians, Chinese, Indians, Malays and Eurasians.
2011,
Pubmed
Herman,
Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program.
2007,
Pubmed
Inoue,
Fasting plasma glucose and HbA1c as risk factors for Type 2 diabetes.
2008,
Pubmed
International Expert Committee,
International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes.
2009,
Pubmed
Jacobsen,
Cohort profile: the Tromso Study.
2012,
Pubmed
Kamycheva,
Insulin sensitivity in subjects with secondary hyperparathyroidism and the effect of a low serum 25-hydroxyvitamin D level on insulin sensitivity.
2007,
Pubmed
Katz,
Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans.
2000,
Pubmed
Little,
Status of hemoglobin A1c measurement and goals for improvement: from chaos to order for improving diabetes care.
2011,
Pubmed
Little,
HbA1c: how do we measure it and what does it mean?
2009,
Pubmed
Lorenzo,
A1C between 5.7 and 6.4% as a marker for identifying pre-diabetes, insulin sensitivity and secretion, and cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study (IRAS).
2010,
Pubmed
Mann,
Impact of A1C screening criterion on the diagnosis of pre-diabetes among U.S. adults.
2010,
Pubmed
Massin,
Hemoglobin A1c and fasting plasma glucose levels as predictors of retinopathy at 10 years: the French DESIR study.
2011,
Pubmed
Matthews,
Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.
1985,
Pubmed
McCance,
Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes.
1994,
Pubmed
Miyazaki,
Comparison of diagnostic methods for diabetes mellitus based on prevalence of retinopathy in a Japanese population: the Hisayama Study.
2004,
Pubmed
Nathan,
Relationship between glycated haemoglobin levels and mean glucose levels over time.
2007,
Pubmed
Nitin,
HbA1c and factors other than diabetes mellitus affecting it.
2010,
Pubmed
Olson,
Screening for diabetes and pre-diabetes with proposed A1C-based diagnostic criteria.
2010,
Pubmed
Pani,
Effect of aging on A1C levels in individuals without diabetes: evidence from the Framingham Offspring Study and the National Health and Nutrition Examination Survey 2001-2004.
2008,
Pubmed
Perry,
HbA1c measurement improves the detection of type 2 diabetes in high-risk individuals with nondiagnostic levels of fasting plasma glucose: the Early Diabetes Intervention Program (EDIP).
2001,
Pubmed
Rahbar,
Studies of an unusual hemoglobin in patients with diabetes mellitus.
1969,
Pubmed
Rathmann,
Hemoglobin A1c and glucose criteria identify different subjects as having type 2 diabetes in middle-aged and older populations: the KORA S4/F4 Study.
2012,
Pubmed
Roberts,
Effects of hemoglobin C and S traits on eight glycohemoglobin methods.
2002,
Pubmed
Sacks,
A1C versus glucose testing: a comparison.
2011,
Pubmed
Sacks,
Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus.
2002,
Pubmed
Saltevo,
Ageing and associations of fasting plasma glucose and 2 h plasma glucose with HbA(1C) in apparently healthy population. "FIN-D2D" study.
2011,
Pubmed
Selvin,
Short-term variability in measures of glycemia and implications for the classification of diabetes.
2007,
Pubmed
Tapp,
Diagnostic thresholds for diabetes: the association of retinopathy and albuminuria with glycaemia.
2006,
Pubmed
Tay,
HbA1c may not be a sensitive determinant of diabetic status in the elderly.
2011,
Pubmed
van Leiden,
Risk factors for incident retinopathy in a diabetic and nondiabetic population: the Hoorn study.
2003,
Pubmed
